Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH)

NAActive, not recruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
Congenital Diaphragmatic Hernia
Interventions
DEVICE

11540KE and Balt Goldbal 2 balloon

Fetoscopic tracheal occlusion will be performed using above devices and reversed after 4-5 weeks.

Trial Locations (1)

21287

Johns Hopkins Center for Fetal Therapy, Baltimore

Sponsors
All Listed Sponsors
collaborator

KARL STORZ Endoscopy-America, Inc.

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT02710968 - Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH) | Biotech Hunter | Biotech Hunter